Lv31
270 积分 2025-04-16 加入
Hepatitis B and D virus entry
19天前
已完结
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
20天前
已完结
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
21天前
已完结
PLA2G12A protects against diet-induced obesity and insulin resistance by enhancing energy expenditure and clearance of circulating triglycerides
25天前
已完结
1-Oleoyl-lysophosphatidylethanolamine stimulates RORγt activity in TH17 cells
25天前
已完结
WED-366 Characterization of BJT-778, an anti-HBsAg neutralizing monoclonal antibody for treatment of hepatitis B virus and hepatitis D virus infections
27天前
已完结
Nirsevimab-resistant respiratory syncytial virus strains are rare but there
28天前
已完结
Molecular surveillance in the nirsevimab era: lessons from respiratory syncytial virus breakthrough infections
28天前
已完结
Activation of the RON Receptor Tyrosine Kinase Inhibits Inducible Nitric Oxide Synthase (iNOS) Expression by Murine Peritoneal Exudate Macrophages: Phosphatidylinositol-3 Kinase Is Required for RON-Mediated Inhibition of iNOS Expression
1个月前
已完结
Inhibition of Interleukin-33 in Diabetic Kidney Disease: A Randomized, Placebo-Controlled Phase 2b Trial
1个月前
已完结
皖公网安备34019202002308
